Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Kinugawa

Showing results (21-30 of 541) with videos related to

Pageof 55
Sort By:
International Heart Journal|January 9, 2016
Preoperative Prediction of Aortic Insufficiency During Ventricular Assist Device TreatmentTeruhiko Imamura, Koichiro Kinugawa
International Heart Journal|January 9, 2016
Centrifugal Pump EVAHEART Prevents Development of Aortic Insufficiency Preserving Pulse PressureTeruhiko Imamura, Koichiro Kinugawa
Medicina (Kaunas, Lithuania)|February 25, 2022
Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart FailureTeruhiko Imamura, Koichiro Kinugawa
The Journal of International Medical Research|November 30, 2022
Effect of add-on sacubitril/valsartan on the left ventricular hypertrophy of a patient with hypertensionTeruhiko Imamura, Koichiro Kinugawa
Medicina (Kaunas, Lithuania)|May 28, 2022
Successful Conversion from Conventional Potassium Binder to Sodium Zirconium Cyclosilicate in a Patient with Refractory ConstipationTeruhiko Imamura, Koichiro Kinugawa
Journal of Cardiology|April 6, 2019
Response by Imamura et al. regarding the article "Update of acute and long-term tolvaptan therapy"Teruhiko Imamura, Koichiro Kinugawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Quality of life after myocardial infarction]Naoko Kato, Koichiro Kinugawa
International Heart Journal|July 15, 2024
Who Can Receive Clinical Benefit from Mid-Term Vericiguat Add-on Therapy Among Patients with Systolic Heart Failure Receiving Quadruple Medical Therapy?Teruhiko Imamura, Koichiro Kinugawa
International Journal of Molecular Sciences|January 20, 2016
Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart FailureTeruhiko Imamura, Koichiro Kinugawa
Journal of Cardiac Failure|January 2, 2022
Globe is Still Heterogenous from the Perspective of Heart FailureNaoko P Kato, Koichiro Kinugawa
Pageof 55

Showing results (21-30 of 541) with videos related to

Sort By:
Pageof 55
International Heart Journal|January 9, 2016
Preoperative Prediction of Aortic Insufficiency During Ventricular Assist Device TreatmentTeruhiko Imamura, Koichiro Kinugawa
International Heart Journal|January 9, 2016
Centrifugal Pump EVAHEART Prevents Development of Aortic Insufficiency Preserving Pulse PressureTeruhiko Imamura, Koichiro Kinugawa
Medicina (Kaunas, Lithuania)|February 25, 2022
Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart FailureTeruhiko Imamura, Koichiro Kinugawa
The Journal of International Medical Research|November 30, 2022
Effect of add-on sacubitril/valsartan on the left ventricular hypertrophy of a patient with hypertensionTeruhiko Imamura, Koichiro Kinugawa
Medicina (Kaunas, Lithuania)|May 28, 2022
Successful Conversion from Conventional Potassium Binder to Sodium Zirconium Cyclosilicate in a Patient with Refractory ConstipationTeruhiko Imamura, Koichiro Kinugawa
Journal of Cardiology|April 6, 2019
Response by Imamura et al. regarding the article "Update of acute and long-term tolvaptan therapy"Teruhiko Imamura, Koichiro Kinugawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Quality of life after myocardial infarction]Naoko Kato, Koichiro Kinugawa
International Heart Journal|July 15, 2024
Who Can Receive Clinical Benefit from Mid-Term Vericiguat Add-on Therapy Among Patients with Systolic Heart Failure Receiving Quadruple Medical Therapy?Teruhiko Imamura, Koichiro Kinugawa
International Journal of Molecular Sciences|January 20, 2016
Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart FailureTeruhiko Imamura, Koichiro Kinugawa
Journal of Cardiac Failure|January 2, 2022
Globe is Still Heterogenous from the Perspective of Heart FailureNaoko P Kato, Koichiro Kinugawa
Pageof 55